Evolus, Inc. EOLS
Set alert
7.27 USD +0.11 +1.47%
As of Nov 3, 1:37 PM ET
7.17 Day range 7.42
3.86 52-week range 9.31
- YTD
- +9.25%
- 1 year
- +13.70%
- Open
- 7.17
- Prev close
- 7.16
- Mkt cap
- 479.86M
- Vol
- 149.83K
- Avg vol
- 899.28K
- EPS
- -0.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.17
- High
- 7.42
- Forward P/E
- 54.20
- Beta
- 1.31
- Short ratio
- 7.38
- Inst. own
- 80.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 31, 2024
- 50-d avg
- 14.00
- 200-d avg
- 13.56
- 1y target
- 23.43
MAX chart
Events in this range
- Mar 7, 2024Earnings: —; estimate -0.07; surprise —%
- May 7, 2024Earnings: -0.13; estimate -0.07; surprise -85.71%
- May 7, 2024Earnings: —; estimate -0.07; surprise —%
- Jul 31, 2024Earnings: -0.07; estimate -0.04; surprise -75%
- Jul 31, 2024Earnings: —; estimate -0.04; surprise —%
- Sep 13, 2024Rating: Needham · Buy → Buy
- Sep 13, 2024Rating: Barclays · Overweight → Overweight
- Sep 16, 2024Rating: Cantor Fitzgerald · — → Overweight
- Oct 3, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 1, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 6, 2024Earnings: -0.19; estimate -0.08; surprise -137.5%
- Nov 7, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (138)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 4 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| RSI: Oversold | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| RSI: Oversold | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
Newest 20 of 138.
Analyst view
Consensus: buy
Buy
Price target (mean) 23.43 +222.5% upside
Now 7.27
- Target (low)
- 20.00
- Target (mean)
- 23.43
- Target (high)
- 27.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy4
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.001 | -0.02 – 0.017 | -0.1449 | +99.3% | 77.23M | +26.6% | 3 |
| Next quarter | -0.012 | -0.012 – -0.012 | -0.10973 | +89.1% | 75.38M | +27.1% | 1 |
| Current year | -0.282 | -0.30 – -0.26 | -0.7198 | +60.8% | 264.21M | +30.7% | 4 |
| Next year | 0.048 | -0.208 – 0.41 | -0.282 | +117.0% | 347.37M | +31.5% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Sep 13, 2024 | Barclays | Maintained | Overweight | Overweight |
| Sep 13, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 1, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| May 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 8, 2024 | Stifel | Reiterated | Buy | Buy |
| Mar 8, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 8, 2024 | Mizuho | Maintained | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 29, 2024 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jan 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 20, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 3, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 3, 2023 | Needham | Reiterated | Buy | Buy |
| Jul 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 7, 2023 | Mizuho | Maintained | Buy | Buy |
| May 26, 2023 | Truist Securities | Maintained | Buy | Buy |
| May 10, 2023 | Needham | Maintained | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 9, 2023 | Needham | Reiterated | — | Buy |
